CAS 869769-98-2

Formula: C30H40F3N5O2

InChI: InChI=1S/C30H40F3N5O2/c1-6-40-25-16-22-15-23(30(31,32)33)7-8-24(22)27(25)38-14-13-37(17-19(38)2)29(5)9-11-36(12-10-29)28(39)26-20(3)34-18-35-21(26)4/h7-8,15,18-19,25,27H,6,9-14,16-17H2,1-5H3/t19-,25+,27+/m0/s1

InChI key: ZMCJFJZOSKEMOM-DNKZPPIMSA-N

SMILES: CCO[C@@H]1CC2=C([C@H]1N3CCN(C[C@@H]3C)C4(CCN(CC4)C(=O)C5=C(N=CN=C5C)C)C)C=CC(=C2)C(F)(F)F

INCB-9471

CAS: 869769-98-2

INCB-9471 is a CCR5 antagonist with anti-HIV activity and inhibits the interaction between HIV-1 gp120.

Formula: C₃₀H₄₀F₃N₅O₂

Purity: 98.89%

Color and Shape: White Solid

Molecular weight: 559.666

Ref: TM-T71665

INCB-9471

CAS: 869769-98-2

INCB-9471

Formula: C₃₀H₄₀F₃N₅O₂

Purity: ≥98%

Molecular weight: 559.666

Ref: 54-BUP03046

INCB9471

CAS: 869769-98-2

Formula: C₃₀H₄₀F₃N₅O₂

Molecular weight: 559.6661

Ref: IN-DA02CQTL

INCB9471

CAS: 869769-98-2

INCB9471 is a drug that inhibits the activity of human immunodeficiency virus (HIV) by binding to the viral reverse transcriptase enzyme. It has been shown to be active against HIV-1 and HIV-2, with low cytotoxicity for cells in vitro. INCB9471 can be used for the treatment of bone cancer or as a diagnostic agent for infectious diseases, such as tuberculosis or hepatitis B. The compound has not been tested in animals or humans for long-term toxicity, bowel disease, primary sclerosing cholangitis, or antiviral resistance. However, it has been shown to be efficacious in treating her2+ breast cancer and long-term efficacy (up to 3 years) in patients with chronic hepatitis C.

Purity: Min. 95%

Ref: 3D-BI178039